TyRx Inc.
Related Content
News | August 15, 2013
The first implantation of Tyrx Inc.’s new AigisRx R Fully Resorbable Antibacterial Envelope has taken place at the...
Feature | May 16, 2013
The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection,...
News | April 15, 2013
Tyrx announced the first implantation of its new AigisRx R Fully Resorbable Antibacterial Envelope has taken place at...
News | April 08, 2013
Tyrx Inc. has received a license from Health Canada to market its new AigisRx R Fully Resorbable Antibacterial Envelope...
News | October 12, 2012
TyRx Inc. announced that it has received a license from Health Canada to market its AigisRx Antibacterial Envelope. The...
News | August 03, 2012
August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid...
News | March 13, 2012
March 20, 2012 - TyRx Inc., a company specializing in the commercialization of implantable medical devices designed to...
News | October 29, 2010
October 29, 2010 – Site enrollment has been completed for the 50-site CITADEL and CENTURION clinical studies to...
News | October 20, 2010
October 20, 2010 – New study results show that patients undergoing cardiac implantable electronic device (CIED)...
Technology | April 14, 2010
April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to...
